Downingtown, PA, United States of America

Reddeppa Reddy Dandu

USPTO Granted Patents = 16 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 48(Granted Patents)

Location History:

San Diego, CA (US) (2018)
Downington, PA (US) (2023)
Downingtown, PA (US) (2013 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

16 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12441702 - Substituted 4-benzyl and 4-benzoyl piperidine derivates (2025-10-14),

2. 12098130 - 1,4-substituted piperidine derivatives (2024-09-24),

3. 11878966 - Substituted 4-benzyl and 4-benzoyl piperidine derivates (2024-01-23),

4. 11702388 - 1,4-substituted piperidine derivatives (2023-07-18),

5. 10919875 - Substituted 4-benzyl and 4-benzoyl piperidine derivatives (2021-02-16),

6. 10851057 - 1,4-substituted piperidine derivatives (2020-12-01),

7. 10221135 - 1,4-substituted piperidine derivatives (2019-03-05),

8. 10017496 - Uracil derivatives as AXL and c-MET kinase inhibitors (2018-07-10),

9. 9902696 - 1,4-substituted piperidine derivatives (2018-02-27),

10. 9745283 - Uracil derivatives as AXL and c-MET kinase inhibitors (2017-08-29),

11. 9522902 - Uracil derivatives as AXL and c-MET kinase inhibitors (2016-12-20),

12. 9120778 - Uracil derivatives as AXL and c-MET kinase inhibitors (2015-09-01),

13. 9029538 - Uracil derivatives as AXL and c-MET kinase inhibitors (2015-05-12),

14. 8716493 - Multicyclic compounds and the use thereof (2014-05-06),

15. 8524713 - [object Object] (2013-09-03),

Title: **Reddeppa Reddy Dandu: Innovator in Pharmaceutical Chemistry**

Introduction

Reddeppa Reddy Dandu is a prolific inventor based in Downingtown, PA, who has made significant contributions to the field of pharmaceutical chemistry. With an impressive portfolio of 15 patents, Dandu specializes in the development of compounds that target critical pathways in disease processes, primarily focusing on fatty acid synthase inhibitors.

Latest Patents

Among Dandu's notable inventions are the 1,4-substituted piperidine derivatives. These compounds, outlined in his latest patents, exhibit strong activity as inhibitors of fatty acid synthase. The patents detail not only the composition of these compounds but also pharmaceutical formulations that can be used to treat diseases associated with fatty acid synthase. Additionally, the patents provide methods for synthesizing these compounds and their synthetic intermediates, showcasing Dandu's comprehensive approach to innovation in drug development. Another significant contribution includes the substituted 4-benzyl and 4-benzoyl piperidine derivatives, reinforcing his ongoing efforts to address medical challenges through innovative chemistry.

Career Highlights

Dandu has collaborated with prominent companies in the pharmaceutical field, notably 89bio, Inc. and Ignyta, Inc. His work in these organizations has allowed him to harness his skills in a collaborative environment, driving the advancement of novel therapeutic agents.

Collaborations

Throughout his career, Dandu has worked alongside esteemed colleagues such as Robert L. Hudkins and Nadine C. Becknell. These collaborations have significantly enriched his professional journey, contributing to the successful development of the patents for which he is recognized.

Conclusion

Reddeppa Reddy Dandu's contributions to pharmaceutical chemistry through his innovative patents reflect a dedication to advancing medical treatment options. His work exemplifies the vital role of inventors in addressing complex health issues, making him a noteworthy figure in the field of drug development and innovation.

This text is generated by artificial intelligence and may not be accurate.